Related Experiment Video
Updated: May 13, 2026

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
No consensus exists for use of anticoagulation for calf vein thrombosis
Michael J Anstadt1, T Calloway Robertson, Ross Milner
1Department of Surgery, Loyola University Medical Center.
Insights
Treatment for calf vein thrombosis (CVT) lacks consensus. Practices vary widely, with nearly half of physicians not using anticoagulation and a notable use of IVC filters for CVT management.
Area of Science:
- Vascular Medicine
- Thrombosis Research
- Medical Practice Patterns
Background:
- Calf vein thrombosis (CVT) treatment guidelines are not well-defined.
- Current clinical practice for CVT management shows significant variability.
- Understanding physician approaches to CVT is crucial for developing standardized protocols.
Purpose of the Study:
- To assess current practice patterns in managing calf vein thrombosis (CVT) at a single institution.
- To identify physician preferences regarding anticoagulation, treatment duration, and use of inferior vena cava (IVC) filters for CVT.
Main Methods:
- An online survey with 8 multiple-choice questions was distributed to physicians.
- The survey focused on the management strategies for calf vein thrombosis.
- Ninety-nine physicians from various specialties participated in the survey.
Main Results:
- Nearly half of physicians (48.5%) anticoagulate patients with CVT, while 51.5% do not.
- Among those using anticoagulation, low molecular weight heparin was preferred (62.3%).
- Treatment durations varied, with 58% opting for 3 months and 30% for 6 months.
- Of physicians not anticoagulating, 71.2% used duplex exams to monitor clot progression.
- Inferior vena cava (IVC) filters were used in 46% of cases with anticoagulation contraindications and 13.7% for clot propagation.
Conclusions:
- There is a significant lack of consensus in the treatment of calf vein thrombosis (CVT).
- The utilization rate of IVC filters for CVT appears higher than anticipated.
- Further research is needed to establish evidence-based guidelines for CVT management.
Abstract:
The ideal treatment of calf vein thrombosis (CVT) remains undefined. We assessed practice patterns at a single institution for CVT. Physicians were sent an online survey with 8 multiple choice questions about management of CVT. A total of 99 physicians of varying specialties participated in the survey. A total of 48.5% anticoagulate patients with CVT and 51.5% do not. Of those who anticoagulate, 62.3% use low molecular weight heparin and 11% use IV heparin. Treatment duration is 3 months for 58% and 6 months for 30% of responders. Of those who do not anticoagulate, 71.2% reassess for clot propagation or resolution with a duplex exam. IVC filters are used by 46% when there is a contraindication to anticoagulation and 13.7% when clot propagation is noted on follow-up scan. These results suggest that there is no consensus treatment of CVT. There is a higher than expected rate of IVC filters placed for CVT.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Varicose Veins II: Diagnostic Studies and Interprofessional Care
